Smita S Chandran

4PUBLICATIONS
20CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 30, 2024
Engineered NKG2C + NK-like T cells exhibit superior antitumor efficacy while mitigating cytokine release syndrome.

Kyle B Lupo, M Kazim Panjwani, Sanam Shahid

|Mar 11, 2024
CAR-engineered lymphocyte persistence is governed by a FAS ligand/FAS auto-regulatory circuit.

Fei Yi, Tal Cohen, Natalie Zimmerman

|Apr 28, 2022
Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA.

Smita S Chandran, Jiaqi Ma, Martin G Klatt

|Jul 30, 2019
T cell receptor-based cancer immunotherapy: Emerging efficacy and pathways of resistance.

Smita S Chandran, Christopher A Klebanoff

Pageof 1